CVS Health ($CVS) reported below-consensus third quarter adjusted earnings. Ingram Micro ($IM) reported better than expected third quarter non-GAAP earnings per share but its revenues trailed expectations. The company’s fourth quarter revenue guidance is weak, although its earnings per share guidance is in line.